NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered Tirzepatide from LiliPeptide? Mail in a sample (US only) and let us test it for free.

Test my supply
+7 more ↓
81%
Finnrick rating
#65 of 262 Tirzepatide vendors
34 of 42 classifiable tests passed
customers 4.7★ (25)
methodology · Purity focus
Finnrick analysis · Tirzepatide

LiliPeptide's tirzepatide has an uneven purity-focused record, with purity misses, a 0 mg identity failure, and major fill swings. Recent passes help, but +54% overfill in May and +33% in June keep quantity consistency in focus.

methodology →
vendor intelligence report
Vendor Intelligence Report: LiliPeptide

Public records and web artifacts leave the listed U.S. location unsupported and point toward a China/Hong Kong operating stack. The report maps the typo-domain network, PeptSlim/ElitePeptide66 overlap, rotating contact personas and post-payment courier-fee complaints.

27 pages5 risk factors assessed3 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.06
94%
28
2
Tirzepatideselected
$0.53
81%
42
3
Retatrutide
$0.93
79%
153
4
SS-31
$1.15
76%
3
5
BPC-157
$0.70
68%
24
6
PT-141
$0.75
66%
9
7
Ipamorelin
$0.95
65%
10
8
Tesamorelin
$2.45
56%
24
9
Melanotan II
$0.55
56%
5
10
Cagrilintide
$25.00
51%
3
11
CJC-IPA
-
38%
1
12
MOTS-c
$0.80
35%
9
13
NAD+
$0.02
26%
4
14
CJC-1295
$2.05
25%
6
15
TB-500
$1.55
22%
15
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%1 Sep 2025: 73%30 Sep 2025: 78%30 Sep 2025: 79%1 Oct 2025: 81%1 Oct 2025: 82%3 Oct 2025: 84%9 Oct 2025: 80%4 Nov 2025: 81%14 Nov 2025: 83%17 Nov 2025: 84%17 Nov 2025: 80%25 Nov 2025: 76%5 Dec 2025: 77%17 Dec 2025: 78%1 Jan 2026: 79%1 Jan 2026: 80%1 Jan 2026: 81%9 Jan 2026: 82%15 Jan 2026: 79%15 Jan 2026: 80%19 Jan 2026: 77%18 Feb 2026: 74%20 Feb 2026: 75%26 Feb 2026: 72%4 Mar 2026: 73%12 Mar 2026: 74%25 Mar 2026: 75%29 Mar 2026: 75%13 Apr 2026: 76%23 Apr 2026: 77%5 May 2026: 78%27 May 2026: 75%4 Jun 2026: 76%4 Jun 2026: 77%12 Jun 2026: 77%1 Jul 2026: 78%13 Jul 2026: 79%21 Jul 2026: 79%21 Jul 2026: 80%30 Jul 2026: 80%2 Aug 2026: 81%24 Sep 2026: 81%29 Sep 2026: current 81%73%79%81%Sep 25Sep 26
Showing Tirzepatide tests only
Free peptide testing

Ordered Tirzepatide from LiliPeptide? Mail in a sample (US only) and let us test it for free.

Test my supply
LiliPeptide Tirzepatide test history
COA-backed lab tests
1-10 of 42

About LiliPeptide test results from Finnrick

LiliPeptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 15 peptides and 336 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible LiliPeptide peptides in this dataset are BPC-157 (24 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 200 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered Tirzepatide from LiliPeptide? Mail in a sample (US only) and let us test it for free.

Test my supply